Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03540069 · ClinicalTrials.gov registry record · NA
Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal
A NA study of Cervical Cancer and Behavior, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 3
- Study locations
NCT03540069 is a NA study of Cervical Cancer and Behavior that has completed, run by University of Illinois at Chicago. The registered enrollment target is 160 participants, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (72% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT03540069, a NA study of Cervical Cancer and Behavior, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research project will investigate the determinants of cervical cancer screening uptake and sustained utilization in this region and develop and evaluate a context-specific peer education behavioral intervention to improve uptake. Research supports the effectiveness of peer education in increasing cancer screening rates but, currently, no cervical cancer screening peer education program specific to rural Senegal exists. To inform the participatory development of this program, the investigators will assess barriers and facilitators of screening at multiple levels: individuals (women aged 30 to 59), households (family or principle social unit of at-risk women), and the community (immediate village or neighborhood with common amenities of at-risk women). We hypothesize that a peer education program that adapts to changing contexts over time and is targeted at a multi-level audience will result in early, widespread uptake and sustained use of the VIA cervical cancer screening program. Study findings will inform programmatic planning in Kedougou and the peer education curriculum we develop can serve as a template for maximizing early impact of new cervical cancer screening services implemented in other areas of rural Senegal. Our long-term goal is to inform national-level policy to guide the implementation of cervical cancer screening programs in other rural Senegal regions.
Conditions Studied
Interventions
- BEHAVIORAL Care Group Cervical Cancer Screening Education Curriculum
Study Locations (3)
Other
- Sénégal Ministère de la Santé et l'Action Sociale Département de Recherche - Dakar
- Université Cheikh Anta Diop, Dakar, Senegal Cancer Institute & Institute of Health and Development - Dakar
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03540069
The ClinicalTrials.gov registry entry for NCT03540069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (72% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Care Group Cervical Cancer Screening Education Curriculum is the first listed.
NCT03540069 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Illinois.
Frequently Asked Questions
What is clinical trial NCT03540069 about?
NCT03540069 is a clinical study titled "Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal". This research project will investigate the determinants of cervical cancer screening uptake and sustained utilization in this region and develop and evaluate a context-specific peer education behavioral intervention to improve uptake. Research supports the effectiveness of peer education in increasi...
What is the current status of trial NCT03540069?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-10-03. Estimated completion is 2021-12-15.
What conditions does trial NCT03540069 study?
This clinical trial studies the following conditions: Cervical Cancer, Behavior.
What interventions are being tested in trial NCT03540069?
The interventions under investigation include: Care Group Cervical Cancer Screening Education Curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT03540069?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03540069 being conducted?
This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.